Kazuhiko Mishima
Saitama International Medical Center(JP)Saitama Medical University(JP)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, CNS Lymphoma Diagnosis and Treatment, Lymphoma Diagnosis and Treatment, Brain Metastases and Treatment, Neuroblastoma Research and Treatments
Most-Cited Works
- → Involvement of the Snake Toxin Receptor CLEC-2, in Podoplanin-mediated Platelet Activation, by Cancer Cells(2007)517 cited
- → Novel, improved grading system(s) for IDH-mutant astrocytic gliomas(2018)463 cited
- → Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain(2006)240 cited
- → Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression(2006)234 cited
- Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor.(2001)
- Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas.(2002)
- → Genomic characterization of primary central nervous system lymphoma